John Ross, Ph.D.

John Ross is Vice President of biologics discovery and preclinical development at Crosslink therapeutics.  Prior to joining Crosslink, Dr. Ross was VP of Protein Therapeutics and co-inventor of key technologies at Cue Biopharma.  Prior to Cue, Dr. Ross had leadership roles in Protein Chemistry and Proteomics, and preclinical development at Wyeth, Aileron Therapeutics, and Permeon Biologics. John’s academic experience includes a B.S. from the University of Michigan, a Ph.D. degree from the Medical College of Ohio, and a postdoctoral position at Harvard University in the laboratory of Brian Dynlacht.